Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Sernova Corp Company Overview 4
Sernova Corp Company Snapshot 4
Sernova Corp Pipeline Products and Ongoing Clinical Trials Overview 4
Sernova Corp – Pipeline Analysis Overview 6
Business Description 6
Sernova Corp – Key Facts 7
Sernova Corp – Major Products and Services 8
Sernova Corp Pipeline Products by Development Stage 9
Sernova Corp Ongoing Clinical Trials by Trial Status 11
Sernova Corp Pipeline Products Overview 13
Cell Pouch System – Hemophilia 13
Cell Pouch System – Hemophilia Product Overview 13
Cell Pouch System – Human Donor Islets 14
Cell Pouch System – Human Donor Islets Product Overview 14
Cell Pouch System – Human Donor Islets Clinical Trial 15
Cell Pouch System – Microencapsulated Porcine Islets 16
Cell Pouch System – Microencapsulated Porcine Islets Product Overview 16
Cell Pouch System – Microencapsulated Stem Cell Derived Cells 17
Cell Pouch System – Microencapsulated Stem Cell Derived Cells Product Overview 17
Cell Pouch System – Thyroid Disease 18
Cell Pouch System – Thyroid Disease Product Overview 18
Sernova Corp – Key Competitors 19
Sernova Corp – Key Employees 20
Sernova Corp – Key Employee Biographies 21
Sernova Corp – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Sernova Corp, Recent Developments 23
Dec 11, 2017: Sernova Receives US FDA IND Allowance to Initiate a US Clinical Trial of its Cell Pouch for the Treatment of Type 1 Diabetes 23
Jul 24, 2017: Sernova-HemAcure Consortium Announce Significant Progress in Development of ‘First in World’ Regenerative Medicine Therapy for Treatment of Hemophilia A Patients 23
Jun 05, 2017: Sernova Provides Company Outlook on Corporate and Clinical Developments 25
Nov 02, 2016: Sernova and CTI Clinical Trial Announce Regulatory Collaboration 25
Sep 30, 2016: Sernova Announces Appointment of New CFO 26
Mar 15, 2016: Sernova Announces First Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update 26
Feb 16, 2016: Sernova Receives First Payment from the European Commission’s Horizon 2020 Grant to Fund Development of a Cell-Based Hemophilia Therapeutic Using the Cell Pouch 27
Dec 21, 2015: Sernova Awarded Europe’s Prestigious Horizon 2020 Grant to Fund Development of Cell-Based Hemophilia Therapeutic Product Into the Clinic 27
Sep 21, 2015: Sernova Announces Listing on OTCQB Exchange 28
Apr 23, 2015: Sernova Receives Issued Patent in the United States for Its Cell Pouch and Therapeutic Cell Transplantation Technologies 28
Appendix 30
Methodology 30
About GlobalData 32
Contact Us 32
Disclaimer 33
Sernova Corp Pipeline Products and Ongoing Clinical Trials Overview 4
Sernova Corp Pipeline Products by Equipment Type 4
Sernova Corp Pipeline Products by Indication 5
Sernova Corp Ongoing Clinical Trials by Trial Status 5
Sernova Corp, Key Facts 7
Sernova Corp, Major Products and Services 8
Sernova Corp Number of Pipeline Products by Development Stage 9
Sernova Corp Pipeline Products Summary by Development Stage 10
Sernova Corp Ongoing Clinical Trials by Trial Status 11
Sernova Corp Ongoing Clinical Trials Summary 12
Cell Pouch System - Hemophilia - Product Status 13
Cell Pouch System - Hemophilia - Product Description 13
Cell Pouch System - Human Donor Islets - Product Status 14
Cell Pouch System - Human Donor Islets - Product Description 14
Cell Pouch System - Human Donor Islets - US Clinical Trial of Cell Pouch System (CPS) for the Treatment of Type 1 Diabetes 15
Cell Pouch System - Microencapsulated Porcine Islets - Product Status 16
Cell Pouch System - Microencapsulated Porcine Islets - Product Description 16
Cell Pouch System - Microencapsulated Stem Cell Derived Cells - Product Status 17
Cell Pouch System - Microencapsulated Stem Cell Derived Cells - Product Description 17
Cell Pouch System - Thyroid Disease - Product Status 18
Cell Pouch System - Thyroid Disease - Product Description 18
Sernova Corp, Key Employees 20
Sernova Corp, Key Employee Biographies 21
Glossary 31